Haegarda

GPTKB entity

Statements (19)
Predicate Object
gptkbp:instanceOf gptkb:drug
gptkbp:activeIngredient C1 esterase inhibitor (human)
gptkbp:approvalYear 2017
gptkbp:approvedBy gptkb:FDA
gptkbp:ATCCode B06AC02
gptkbp:form lyophilized powder for solution for injection
https://www.w3.org/2000/01/rdf-schema#label Haegarda
gptkbp:indication prevention of hereditary angioedema attacks
gptkbp:manufacturer gptkb:CSL_Behring
gptkbp:prescriptionStatus prescription only
gptkbp:routeOfAdministration subcutaneous injection
gptkbp:sideEffect dizziness
headache
injection site reaction
hypersensitivity
gptkbp:storage refrigerated
gptkbp:usedFor gptkb:hereditary_hemorrhagic_telangiectasia
gptkbp:bfsParent gptkb:C1_esterase_inhibitor
gptkbp:bfsLayer 8